Joana D.
- Country
- Lithuania
- Department
- Rheumatology
Research Overview
- Baricitinib Versus TNF Inhibitors for Venous Thromboembolism Risk in Rheumatoid Arthritis: Phase 3b/4 Active-Controlled Study
- A Phase 3 randomized, placebo-controlled, double-blind, parallel-group program to evaluate efficacy and safety of filgotinib in adult subjects with active axial spondyloarthritis
Data & Insights
Has run more than one trial at 29 of 172 partner sites.
Specializations
Rheumatology Focus
This investigator specializes in studying axial spondyloarthritis, a chronic inflammatory arthritis affecting the spine and sacroiliac joints. Their research encompasses evaluation of innovative therapeutic approaches for managing inflammatory rheumatic conditions.
- Inflammatory Spinal Disorders
- Chronic Arthritis Management
- Autoimmune Conditions
Their work contributes to advancing treatment options for patients with chronic inflammatory spinal conditions.
Therapeutic Development
The investigator focuses on evaluating novel therapeutic agents for inflammatory rheumatic diseases. Their expertise includes assessing treatment efficacy in managing signs and symptoms of rheumatological conditions.
- Treatment Response Assessment
- Clinical Efficacy Evaluation
- Therapeutic Innovation
Their research aims to expand therapeutic options for patients with chronic inflammatory conditions.
Clinical Research
The investigator conducts research in advanced therapeutic applications for rheumatological disorders. Their work involves evaluating treatment outcomes in chronic inflammatory conditions.
- Disease Activity Assessment
- Patient Response Monitoring
- Treatment Effectiveness
Their expertise extends to conducting systematic evaluations of therapeutic interventions in rheumatology.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.